Hang Shu
Hefei, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Fusobacterium nucleatum alleviates alcohol-associated liver disease through mannose-mediated elevation of Fbp1 and modulation of gut microbiota.
Journal: Journal of hepatology
Published: August 21, 2025
Lachnospiraceae bacterium alleviates alcohol-associated liver disease by enhancing N-acetyl-glutamic acid levels and inhibiting ferroptosis through the KEAP1-NRF2 pathway.
Journal: Gut microbes
Published: June 13, 2025
Efficacy and safety of Tripterygium wilfordii glycosides tablets combined with Western medicine for patients with rheumatic immune diseases.
Journal: World journal of clinical cases
Published: April 11, 2024
The gut microbiota-produced vitamin B6 mitigates alcohol-associated liver disease by attenuating hepatic oxidative stress damage.
Journal: Hepatology communications
Published: March 05, 2024
PIAS family gene expression: implications for prognosis, immunomodulation, and chemotherapy response.
Journal: American journal of translational research
Published: February 20, 2024
A novel prognostic and therapeutic target biomarker based on complement-related gene signature in gastric cancer.
Journal: Translational cancer research
Published: April 10, 2023
Endostar Synergizes with Radiotherapy to Inhibit Angiogenesis of Cervical Cancer in a Subcutaneous Xenograft Mouse Model.
Journal: Frontiers in bioscience (Landmark edition)
Published: May 10, 2022
The Efficacy and Safety of Continuous Intravenous Endostar Treatment Combined With Concurrent Chemoradiotherapy in Patients With Locally Advanced Cervical Squamous Cell Carcinoma: A Randomized Controlled Trial.
Journal: Frontiers in oncology
Published: June 10, 2021
Nimotuzumab Combined With Irradiation Enhances the Inhibition to the HPV16 E6-Promoted Growth of Cervical Squamous Cell Carcinoma.
Journal: Frontiers in oncology
Published: March 29, 2020
Last Updated: 09/26/2026